{"transactions":[{"id":2096681,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":121880,"kind":"person","name":"JASINOWSKI JERRY J","position":1,"cik":"0001204048","reported_name":"JASINOWSKI JERRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2022-12-06T01:56:00.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":28235,"price":21.25,"value":599993.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 1, 2022, the Issuer and Mr. Jasinowski entered into a Subscription Agreement (the \"Agreement\"). Pursuant to the Agreement, Mr. Jasinowski purchased 28,235 shares of  the Issuer's Series C Convertible Preferred Stock at a price per share of $21.25, for an aggregate purchase price of approximately $600,000."}],"balance_after":28235,"source":{"system":"sec-edgar","filing":"0001104659-22-124667","document":"tm2231996-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465922124667/tm2231996-1_4seq1.xml","form_type":"4"}},{"id":3289226,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":121880,"kind":"person","name":"JASINOWSKI JERRY J","position":1,"cik":"0001204048","reported_name":"JASINOWSKI JERRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-06T02:45:32.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":526316,"price":0.19,"value":100000.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 3, 2020, the Issuer and Mr. Jasinowski entered into a Stock Purchase Agreement (the \"Agreement\").  Pursuant to the Agreement, Mr. Jasinowski purchased 526,316 shares of the Issuer's Common Stock at a price per share of $0.19, for an aggregate purchase price of approximately $100,000."}],"balance_after":1891347,"source":{"system":"sec-edgar","filing":"0001104659-20-011526","document":"tm206922-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920011526/tm206922-1_4.xml","form_type":"4"}},{"id":3914359,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":121880,"kind":"person","name":"JASINOWSKI JERRY J","position":1,"cik":"0001204048","reported_name":"JASINOWSKI JERRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2018-05-31T01:57:51.000Z","date":"2018-05-28","kind":"grant","acquired":true,"shares":4900000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These 4,900,000 Options were previously reported and were approved by shareholders at the Special Shareholder Meeting on April 27, 2018.  Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price of the Options is $0.23."}],"balance_after":4900000,"derivative":{"exercise_price":0.23,"exercise_date":"2018-05-28","expiration_date":"2028-05-28","underlying":"Common Stock, par value $0.001","underlying_shares":4900000},"source":{"system":"sec-edgar","filing":"0001144204-18-031797","document":"tv495289_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000114420418031797/tv495289_4.xml","form_type":"4"}}]}